Infection and Immunity, July 1999, p. 3188-3192, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Division of Comparative Medicine, Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, Florida 32610-0001
Received 7 January 1999/Returned for modification 11 February 1999/Accepted 6 April 1999
| |
ABSTRACT |
|---|
|
|
|---|
Mycoplasma fermentans incognitus has been isolated from
human tissue in patients both with and without AIDS who died of
systemic infection. M. fermentans incognitus and other
strains of M. fermentans have been associated with
rheumatoid arthritis. While cell extracts of M. fermentans
incognitus can induce changes in murine and human cells of the
monocytic lineage, little is known about interactions of viable
organisms with such cells. Because of the central role of macrophages
in chronic inflammation, we examined the effects of M. fermentans incognitus on surface markers and functions of THP-1
cells, a well-characterized human monocytic cell line. This cell line
has been used extensively in studies of macrophage differentiation, especially following exposure to phorbol esters. Changes in cell morphology, phagocytosis, rate of cell division, and selected surface
markers were evaluated in cultures of THP-1 cells exposed to phorbol
myristate acetate (PMA), M. fermentans incognitus, or both.
As reported by other investigators, PMA induced THP-1 cells to
differentiate into cells resembling tissue macrophages. M. fermentans incognitus only minimally affected changes induced by
PMA, slightly increasing the percentage of cells positive for FC
RI
and major histocompatibility complex (MHC) class II antigens. M. fermentans incognitus alone induced an incomplete arrest in the
cell cycle at G0 phase, increased phagocytic ability, and enhanced expression of FC
RI, CR3, CR4, and MHC class II antigens.
| |
INTRODUCTION |
|---|
|
|
|---|
Macrophages serve a wide range of
functions in host defense and inflammation, including antigen
presentation, cytokine secretion, phagocytosis, and microbial and tumor
cell killing (2, 4). After differentiation, their functional
repertoire can be altered, and it is largely determined by the
surrounding tissue microenvironment (the surrounding cells and their
secreted products). Phorbol esters, such as phorbol 12-myristate
13-acetate (PMA), are capable of inducing complete differentiation of
monocytes into tissue macrophages (4, 5). PMA-induced
differentiation occurs through activation of protein kinase C (PKC) and
resembles diacylglycerol-induced differentiation, which occurs
naturally (14, 19). Phenotypically, macrophages induced by
PMA resemble resident tissue macrophages in having reduced expression
of FC
RI and major histocompatibility complex (MHC) class II antigens
and increased expression of the complement receptors CR3 (CD18-CD11b)
and CR4 (CD18-CD11c) (3, 21).
In contrast, inflammatory macrophages express greater amounts of
FC
RI and MHC class II antigens and have enhanced phagocytic ability
(2). Enhanced expression of FC
RI correlates with
antibody-dependent cell cytotoxicity. Activation of FC
RI also leads
to activation of phospholipase A2 and the proinflammatory
arachidonic acid cascade (2). Enhanced MHC class II
expression correlates with effective antigen-presenting capacity
(2, 8, 27).
Various Mycoplasma fermentans cell components have
immunomodulatory effects on monocytes, resulting in secretion of
proinflammatory cytokines (tumor necrosis factor [TNF], interleukin 1 [IL-1], and IL-6), alterations in expression of MHC class II
antigens, arrest of cell division, and induction of differentiation
(8-10, 12, 22, 27). However, the functional capabilities of
M. fermentans-differentiated macrophages have not been
described. Our objective was to determine the effect of M. fermentans incognitus infection on the differentiation and
functional capacity of THP-1 cells, a monocytoid leukemic cell line, by
assessing changes in cell cycle, cell morphology, phagocytic ability,
and expression of MHC class II antigens, FC
RI, and complement
receptors CR3 and CR4.
We examined the effect of M. fermentans incognitus on THP-1
cells that were either resting or differentiating in response to PMA.
M. fermentans incognitus did not induce complete
differentiation in resting THP-1 cells, but exposure did increase the
phagocytic ability and enhance expressions of FC
RI, CR3, CR4, and
MHC class II antigens. Furthermore, M. fermentans incognitus
altered the phenotypes of cells induced to differentiate by PMA so that
the cells resembled inflammatory macrophages rather than resident tissue macrophages.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Mycoplasmas.
M. fermentans incognitus was used for all
experiments. This culture was the seventh passage of a stock culture
obtained from J. G. Tully, National Institutes of Health. To
ensure identical inocula for all experiments, a large-volume culture
was grown to late log phase in SP4 medium, and 5-ml aliquots were
frozen at
80°C. The frozen inoculum contained 108 CFU
per ml of broth. In preliminary experiments, we found that M. fermentans continued to grow in our THP-1 cell culture system and
that the number of final CFU varied until this system was saturated.
After saturation, there was little change in the number of CFU during
the period in which these experiments were conducted. We therefore
could not test differing doses, and to reduce variability, we saturated
our cultures by using inocula that contained the highest number of CFU
(108 CFU/ml of RPMI 1640 medium) that did not kill THP-1
cells over a 1-week period. Prior to inoculation into THP-1 cell
cultures, the mycoplasmas were washed three times in sterile,
endotoxin- and preservative-free 0.9% saline and resuspended in
sterile, antibiotic- and endotoxin-free RPMI medium containing 10%
fetal calf serum and 25 mM HEPES. For the duration of each experiment, all THP-1 cultures infected with M. fermentans incognitus
received only one inoculum. For each experiment, the concentration of
viable organisms in the prepared inoculum was verified by culture.
THP-1 cell cultures. Mycoplasma-free THP-1 cells obtained from the American Type Culture Collection (Manassas, Va.) were maintained at 37°C, 5% CO2, and 95% relative humidity (RH) in antibiotic- and endotoxin-free RPMI medium containing 10% fetal calf serum and 25 mM HEPES. Both cell extracts and cell supernatants were repeatedly screened by PCR for mycoplasmal contamination. DNA was extracted from the samples by proteinase K digestion (23). The primers used detected a 16S ribosomal gene sequence that is characteristically present in the class Mollicutes. The primers used were (from the 5' to 3' sequence) P1, AGAGTTGATCCTGGCTCAGGA-3' (23), and MGSO, TCGACCATCTGTCACTCTGTTAACCTC (13), which yielded a 1,042-bp product. For amplification of DNA, the PCR assay was performed in 50 µl of reaction mixture containing 50 mM Tris-HCL, 50 mM NaCl, 2 mM MgCl2, a 0.5 µM concentration of each primer, a 200 mM concentration of each deoxynucleoside triphosphate, and 2.5 U of Taq DNA polymerase (Promega, Madison, Wis.). This assay consistently detects mycoplasmal DNA extracted from cultures containing 100 CFU/µl. DNA from mycoplasmal cultures was extracted by proteinase K digestion. Each THP-1 cell sample had a corresponding positive control containing 10 copies of either Mycoplasma pulmonis or M. fermentans DNA. The thermal profile involved one 5-min delay cycle at 95°C followed by 40 cycles of denaturation at 94°C for 1 min, primer annealing at 55°C for 1 min, and primer extension at 72°C for 1 min. Twenty-microliter aliquots of the amplified product were analyzed on a 1.5% agarose gel. DNA was stained with ethidium bromide.
PMA treatments.
A 10
7 M concentration of PMA
(Sigma, St. Louis, Mo.) in RPMI medium was used to differentiate THP-1
cells. The differentiation-inducing dose of 10
7 M PMA for
THP-1 cells was determined in preliminary dose-response experiments
(data not shown). The criteria for differentiation of THP-1 cells were
cell adherence, changes in cell morphology, and changes in the cell
surface marker expression profile (integrin, FC
RI, CD4, and MHC
class II antigen) that is associated with the macrophage phenotype. A
10
2 M stock solution of PMA was prepared by dissolving
PMA in sterile dimethylsulfoxide (Sigma). The stock solution was stored
frozen at
20°C. Immediately prior to use, the PMA stock solution
was diluted in RPMI medium to 10
7 M concentration.
Cell surface markers.
Nonadherent cells were detached by
gentle scraping with a sterile rubber policeman. The cells were counted
in a hemocytometer, and viability was assessed by trypan blue
exclusion. THP-1 cells were examined by flow cytometry for changes in
CR3 and CR4, FC
RI, and MHC class II antigen expression. The
following monoclonal antibodies were used to detect changes in cell
surface marker expression: for CR3, we used phycoerythrin (PE)-labeled
anti-CD11b (IV MO47; Pharmingen, San Diego, Calif.); for CR4, we used
PE-labeled anti-CD11c (IV NO12; Pharmingen), fluorescein isothiocyauate
(FITC)-labeled anti-CD64 (10.1; Pharmingen) and FITC-labeled
anti-HLA-DR, -DP, and -DQ (TU39; Pharmingen). Both FITC- and PE-labeled
mouse immunoglobulin G1 (MOPC-21; Pharmingen) were included
as isotype controls. Approximately 0.5 × 106 to
1 × 106 cells were prepared and stained with each
antibody according to the manufacturer's protocol. Briefly, the cells
were pelleted by centrifugation at 400 × g, washed
with sterile phosphate-buffered saline containing 0.1% sodium azide,
and then stained with the appropriate monoclonal antibody. The cells
were analyzed for forward and side scatter characteristics and for
one-color fluorescence with a FACScan (Becton Dickinson, San Jose,
Calif.). SPHERO 3.0-µm Rainbow Fluorescent Particles (Pharmingen)
were used in each experiment to calibrate fluorescence intensity. The
results were analyzed with PC Lysis software (Becton Dickinson); only
samples that were at least 1% positive for each marker were analyzed
for mean fluorescence.
Cell cycle analysis. Adherent cells were detached by a rubber policeman and were counted in a hemacytometer, and viability was assessed by trypan blue exclusion. The cells were washed once with sterile phosphate-buffered saline and lysed, and the cell DNA was stained with ethidium bromide as previously described (20). Using a FACScan (Becton Dickinson, Mountain View, Calif.), the nuclear DNA content was determined by simultaneous flow cytometric measurements of ethidium bromide fluorescence and the side scatter intensity of cell nuclei. The percentages of cells in G0-G1 phase, S phase, and G2 phase were analyzed by MODFIT for Windows (Verity Software House, Topsham, Maine).
Phagocytosis assays. Monolayers of THP-1 cells were washed twice with sterile RPMI medium and then incubated with 0.2% 0.7-µm-diameter sterile latex-coated polystyrene beads (Sigma) at 37°C, 5% CO2, and 95% RH. At 2, 4, 6, and 8 h of incubation, at least 200 cells from each sample were counted. Cells that contained at least five beads were considered positive for phagocytosis.
Experimental design.
THP-1 cells were cultured in
multiple-well tissue culture plates at a concentration of
106/ml and incubated at 37°C, 5% CO2, and
95% RH. The cell cultures were divided into four treatment groups:
control (untreated), M. fermentans incognitus only, PMA
only, and M. fermentans incognitus combined with PMA. Each
treatment group had at least three to five replicates per experiment.
The cells in each group were examined for changes in cell morphology,
cell cycle, phagocytic ability, and expression of CR3 and CR4 receptors
(CD11b and CD11c), FC
RI (CD64), and MHC class II antigen (HLA-DR,
-DP, and -DQ). All assays were done at 24, 48, and 72 h
poststimulation. In order to avoid complications from nutrient
depletion, the RPMI medium in all treatment groups was changed daily.
Cells treated with PMA received RPMI medium containing freshly prepared
10
7 M PMA. MFI-infected cultures were inoculated once;
therefore, subsequent medium changes were done with RPMI and/or RPMI
containing PMA.
Statistical analysis. Analyses were performed with the Statview SE computer program (ABACUS Concepts, Berkeley, Calif.). Parametric data were analyzed by two-way and one-way analysis of variance followed by Fisher's test for multiple-means comparison.
| |
RESULTS |
|---|
|
|
|---|
Cell adherence and morphology. Control THP-1 cells maintained a round shape and did not clump or adhere to the culture plate surface. More than 90% of M. fermentans incognitus-infected and non-M. fermentans incognitus-infected THP-1 cells treated with PMA aggregated, became flat and amoeboid, and adhered to the culture plate surface. There were no obvious differences in cell shape or percentage of adhered cells between these two groups. Cells that received only M. fermentans incognitus displayed marked clumping; only 5 to 10% of these cells displayed a flat, amoeboid shape. Approximately 40 to 50% of these cells adhered to the culture plate surface.
Phagocytosis assay.
The ability of THP-1 cells to phagocytize
latex beads is summarized in Fig. 1.
Cells exposed to M. fermentans incognitus PMA, or both
displayed significantly greater phagocytosis than control cells
(P
0.0001). Regardless of the stimulus, maximum
phagocytosis occurred by 4 h of incubation for cells that had been
in culture for either 48 or 72 h. In contrast, cells in culture
for only 24 h required exposure to latex beads for 6 to 8 h
for maximum phagocytosis. Among cells that had been cultured for
24 h, those that received both PMA and M. fermentans
incognitus exhibited greater phagocytosis than cells that received
either agent alone (P < 0.0001). This was not seen in
cells that had been cultured for either 48 or 72 h, except at
2 h of incubation.
|
Cell cycle studies.
All cultures initially contained 2 × 106 THP-1 cells. Following 24 h in culture, there were
no differences in numbers of cells between groups. By 48 h,
cultures containing PMA had significant decreases in cell numbers
(P < 0.0001), although the remaining cells were able
to exclude trypan blue (Table 1).
Cultures containing both M. fermentans incognitus and PMA
had significantly more cells (P < 0.0001) than those
containing PMA alone. After 24 h in culture, there were no
differences in the percentages of cells in
G0-G1 phase in any treatment group (data not
shown). Trends were the same following 48 and 72 h in culture;
only the data for 72-h cultures are presented in Fig.
2. PMA significantly decreased the
percentage of cells in S phase (P < 0.0001) and
increased the percentage in G2 phase (P < 0.0001). M. fermentans incognitus alone induced small,
but statistically significant (P < 0.0001), decreases
in the percentage of cells in S phase and corresponding increases in
the percentage of cells in G0-G1 phase
(P < 0.02). M. fermentans incognitus did
not significantly alter the proportion of cells in various phases of
the growth cycle following exposure to PMA.
|
|
Changes in cell surface marker expression.
Data regarding the
expression of cell surface markers are expressed as percentages because
of the drop in cell numbers in cultures exposed to PMA. Only data from
the 72-h time point are shown in Fig.
3 to
5. In cultures containing M. fermentans incognitus only, there was a slight increase in the
percentage of cells expressing CR4 and more than an eightfold increase
in cells expressing CR3 (Fig. 3A) (P < 0.001). While
PMA did not significantly increase the percentage of cells expressing
either CR3 or CR4, it significantly increased the expression of both
markers on positive cells (Fig. 3B) (P < 0.0001). As
shown in Fig. 4A, M. fermentans incognitus significantly
increased the percentage of cells expressing FC
RI (P < 0.001) and PMA significantly decreased (P < 0.001) the percentage of cells expressing this marker. There was
some suggestion that M. fermentans incognitus and PMA were
antagonistic inasmuch as there was a small, but significant, difference
in the percentage of cells expressing this marker in cultures
containing PMA alone and those containing both PMA and M. fermentans incognitus (P < 0.001). Due to the
autofluoresence of PMA-treated cultures, changes in the intensity of
FC
RI could not be assessed; however, M. fermentans
incognitus increased the expression of this marker on positive cells
(Fig. 4B). Figure 5A shows that exposure to either PMA or M. fermentans incognitus significantly decreased (P < 0.0001) the percentage of cells positive for MHC class II antigens. Again, due to autofluorescence, intensity of expression could
not be evaluated in cultures treated with PMA, but M. fermentans incognitus increased the intensity of expression of the
marker (P < 0.0001).
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
THP-1 is a well-characterized human monocytic leukemic cell line;
the cells resemble monocytes with respect to several criteria (4,
5) and can be differentiated into macrophage-like cells by
treatment with PMA (4, 5). PMA-induced differentiation is
associated with alterations in cell morphology, cell adherence, and
expression of several genes (4). The changes in cell
morphology, adherence, phagocytosis, and cell surface receptors noted
in the these studies have been reported previously by Auwerx et al.
(4, 5). Furthermore, PMA is known to induce cell cycle
arrest in both G0-G1 and G2 phases
through activation of PKC (14). We also found significant
decreases in the number of cells in culture, which suggests that cell
death may also be occurring. PMA induces apoptosis in other cell lines
(7, 18), which may be related to PKC activation (7,
18). M. fermentans incognitus infection of PMA-treated
cells did not greatly alter the effects of PMA on THP-1 cells, although
phagocytosis and expression of both FC
RI and MHC class II antigens
were significantly increased. Further studies would be required to
determine if these differences are biologically relevant in terms of
macrophage function.
M. fermentans incognitus also induces changes in the THP-1
phenotype, but the final phenotype following M. fermentans
incognitus exposure differs significantly from that induced by PMA.
Cells exposed to MFI do not display amoeboid characteristics (data not shown), do not undergo complete arrest in cell division (Fig. 2), and
have significant increases, instead of decreases, in the percentage of
cells positive for FC
RI (Fig. 4). In addition, the magnitude of cell
loss in cultures exposed to M. fermentans incognitus is much
less than that in cultures exposed to PMA. However, increased
phagocytosis, increased expression of CR3 and CR4, and a decrease in
the percentage of cells expressing MHC class II molecules are similar
in cells exposed to M. fermentans incognitus and those
exposed to PMA. This suggests that THP-1 cells are activated by both
M. fermentans incognitus and PMA and that the two agents
activate different, but overlapping, cellular mechanisms.
Phorbol esters, such as PMA, are thought to regulate gene expression
principally through the activation of PKC, a family of structurally
related kinases with potentially unique activation requirements and
substrate specificities (14, 19). Specific PKC isoenzyme
activities correlate with specific biological functions. For example
activation of PKC-
, and -
correlates with myeloid cell
differentiation (14), which encompasses cell cycle arrest. Bacterial phospholipase can also activate PKC isoforms and other membrane phospholipids, some of which can modulate PKC's effects (19). Mycoplasmas, including M. fermentans
incognitus, are known to possess membrane-bound phospholipase C
(26), which is capable of producing diacylglycerol and
inositol 1,4,5-triphosphate (IP3). Both agents modulate PKC
activity, diacylglycerol through its direct activation, and indirectly
through IP3-mediated Ca2+ mobilization
(19). IP3 can modulate the state of activation in Ca2+-dependent PKC isoenzymes (19). It is
probable that the overlapping effects of M. fermentans
incognitus and PMA on THP-1 cells occur through PKC modulation.
Changes in FC
RI, CR3, and CR4 expression are dependent on cell cycle
arrest but not on PKC activation (5). For instance, PKC
inhibitors do not alter PMA-induced changes in expression of FC
RI,
CR3, and CR4 (5). Our data suggest that M. fermentans incognitus alters expression of FC
RI, CR3, and CR4
without inducing complete cell cycle arrest. Between MFI-treated and
control cultures, there is no significant decrease of cells in S phase
and no increase in cells in the G2-M phase, both of which
occur in PMA-treated cultures. Thus, for at least 72 h, the cell
cycle is not arrested in cultures treated with M. fermentans
incognitus only. Integrin expression (CR3 and CR4) on phagocytes can be
regulated through TNF (3). A likely explanation is that
M. fermentans incognitus induces THP-1 cells to produce
cytokines that alter the expression of these markers. M. fermentans cell extracts can induce monocytes and macrophages to
produce TNF-
and IL-1 (9, 17, 22). Cytokine receptors
modulate intracellular signaling through the JAK family of kinases
(11), which in turn stimulates gene transcription. Both
Fc
RI and integrin molecules are involved in inflammatory processes.
Engagement of Fc
RI potentiates the inflammatory process through
antibody-dependent cell cytotoxicity and activation of phospholipase A
and production of arachidonic acid (2). The expression of
integrin molecules (CR3 and CR4) is necessary for cell-to-cell adhesion
and leukocyte trafficking to sites of inflammation (3).
Thus, M. fermentans incognitus can increase the
proinflammatory capacities of these cells.
MHC class II expression is typically an expression of macrophage activation and can be induced by exposure to gamma interferon or macrophage-activating factor (2, 8). There is conflicting evidence regarding the effects of M. fermentans incognitus on expression of MHC class II antigens. Killed M. fermentans incognitus induces MHC class II expression in both human and murine monocytic cells (27). However, others have found that lipid extracts from M. fermentans D15-86 suppresses gamma interferon-induced expression of MHC class II antigens on monocytic cells (8). Our data show that viable M. fermentans incognitus decreases the percentage of cells that are positive for MHC class II expression but that intensity of expression increases per positive cell, suggesting M. fermentans incognitus exposure induces THP-1 cells to differentiate into more than one subpopulation.
M. fermentans has been implicated in human disease since it was isolated from the joints of patients with leukemia or rheumatoid arthritis (24, 25). More recently, the incognitus strain of the organism has been identified in the tissues of patients both with and without AIDS and is thought to induce both respiratory and systemic disease in some individuals (6, 15, 16). Our data, along with those of others, indicate that M. fermentans incognitus induces changes in cells of the monocytic lineage that may contribute to disease pathogenesis through increased phagocytosis (1), alterations in local cytokine networks (9, 12, 17, 22, 28), and altered presentation of antigens (8, 27). Alterations in cytokine networks, along with alterations in antigen presentation, may lead to changes in T-helper-cell activity and could lead to autoimmune mechanisms.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the National Institutes of Health grant RO1AI33164. L. Reyes was supported by a fellowship from the National Institutes of Health (T32RR07001).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Comparative Medicine, Department of Pathobiology, Box 10006, HSC, University of Florida, Gainesville, FL 32610-0001. Phone: (352) 846-2789. Fax: (352) 846-2781. E-mail: lreyes{at}upha.health.ufl.edu.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abe, T., M. Ohno, T. Sato, M. Murakami, M. Kajiki, and R. Kodara. 1991. "Differentiation induction" culture of human leukemic myeloid cells stimulates high production of macrophage differentiation inducing factor. Cytotechnology 5:S75-S93. |
| 2. | Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283-318[Medline]. |
| 3. |
Arnaout, M. A.
1990.
Structure and function of the leukocyte adhesion molecules CD11/CD18.
Blood
75:1037-1050 |
| 4. | Auwerx, J. 1991. The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47:22-31[Medline]. |
| 5. | Auwerx, J., B. Staels, F. Van Vaeck, and J. L. Ceuppens. 1992. Changes in IgG Fc receptor expression induced by phorbol 12-myristate 13-acetate treatment of THP-1 monocyte leukemia cells. Leukoc. Res. 16:317-327. |
| 6. | Beecham, H. J., III, S. C. Lo, D. E. Lewis, S. W. Comer, K. J. Riley, and E. C. Oldfield, III. 1991. Letter Lancet 338:1014-1015[Medline]. |
| 7. | De Vente, J., S. Kiley, T. Garris, W. Bryant, J. Hooker, K. Posekany, P. Parker, P. Cook, D. Fletcher, and D. K. Ways. 1995. Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Differ. 6:371-382[Abstract]. |
| 8. | Frisch, M., G. Gradehandt, and P. F. Mulradt. 1996. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type 1 interferon, prostaglandins or nitric oxide. Eur. J. Immunol. 26:1050-1057[Medline]. |
| 9. | Gallily, R., M. Salman, M. Tarshis, and S. Rottem. 1992. Mycoplasma fermentans (incognitus strain) induces TNF-alpha and IL-1 production by human monocytes and murine macrophages. Immunol. Lett. 34:27-30[Medline]. |
| 10. | Hall, R. E., S. Agarwal, D. P. Kestler, J. A. Cobb, K. M. Goldstein, and N. Chang. 1996. cDNA and genomic cloning and expression of the p48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product. Biochem. J. 319:919-927. |
| 11. | Karnitz, L. M., and R. T. Abraham. 1995. Cytokine receptor signaling mechanisms. Curr. Opin. Immunol. 7:320-326[Medline]. |
| 12. |
Kostyal, D. A.,
G. H. Butler, and D. H. Beezhold.
1994.
A 48 kilodalton Mycoplasma fermentans membrane protein induces cytokine secretion by human monocytes.
Infect. Immun.
62:3793-3800 |
| 13. |
Kuppeveld, F. J. M.,
J. T. M. Van Der Logt,
A. F. Angulo,
M. J. Van Zoest,
W. G. V. Quint,
H. G. M. Niesters,
J. M. D. Galama, and W. J. G. Melchers.
1992.
Genus-and species-specific identification of mycoplasmas by 16S rRNA amplification.
Appl. Environ. Microbiol.
58:2606-2615 |
| 14. | Livneh, E., and D. D. Fishman. 1997. Linking protein kinase C to cell-cycle control. Eur. J. Biochem. 248:1-9[Medline]. |
| 15. | Lo, S. C., M. M. Hates, R. Y. Wang, P. F. Pierce, H. Kotani, and J. W. Shih. 1991. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 338:1415-1418[Medline]. |
| 16. | Lo, S. C., D. J. Wear, S. L. Green, P. G. Jones, and J. F. Legier. 1993. Adult respiratory distress syndrome without systemic disease associated with infections due to Mycoplasma fermentans. Clin. Infect. Dis. 17:S259-S263. |
| 17. |
Muhlradt, P. F.,
H. Quentmeier, and E. Schmitt.
1991.
Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product.
Infect. Immun.
59:3962-3968 |
| 18. |
Munn, D. H.,
A. C. Beall,
D. Song,
R. W. Wrenn, and D. C. Throckmorton.
1995.
Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon gamma.
J. Exp. Med.
181:127-136 |
| 19. | Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484-496[Abstract]. |
| 20. | Nusse, M., W. Beisker, C. Hoffman, and A. Tarnok. 1990. Flow cytometric analysis of G1- and G2/M phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry 11:813-821[Medline]. |
| 21. | Prieto, J., A. Eklund, and M. Patarroyo. 1994. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol. 156:191-211[Medline]. |
| 22. | Rawadi, G., and S. Roman-Roman. 1996. Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun. 64:637-643[Abstract]. |
| 23. | Robertson, J. A., A. Vekris, C. Bebear, and G. W. Stemke. 1993. Polymerase chain reaction using 16s rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J. Clin. Investig. 31:824-830. |
| 24. |
Schaeverbeke, T.,
C. B. Gilroy,
C. Bebear,
J. Dehais, and D. Taylor-Robinson.
1996.
Mycoplasma fermentans, but not M. penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders.
J. Clin. Pathol.
49:824-828 |
| 25. |
Schaeverbeke, T.,
H. Renaudin,
M. Clerc,
L. Lequen,
J. P. Vernhes,
B. De Barbeyrac,
B. Bannwarth,
C. Bebear, and J. Dehaus.
1997.
Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples.
Br. J. Rheumatol.
36:310-314 |
| 26. | Shibata, K., T. Sasaki, and T. Watanabe. 1995. AIDS-associated mycoplasmas possess phospholipase C in the membrane. Infect. Immun. 63:4174-4177[Abstract]. |
| 27. | Stuart, P. M., R. M. Egan, and J. G. Woodward. 1993. Characterization of MHC induction by Mycoplasma fermentans (incognitus strain). Cell Immunol. 152:261-270[Medline]. |
| 28. |
Sugama, K.,
K. Kuwano,
M. Furukawa,
Y. Himeno,
T. Satoh, and S. Arai.
1990.
Mycoplasmas induce transcription and production of tumor necrosis factor in a monocytic cell line, THP-1, by a protein kinase C-independent pathway.
Infect. Immun.
58:3564-3567 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|